Actively Recruiting

Age: 18Years +
All Genders
ID07464574

Using Pharmacy Extenders to Optimize Non-statin Agents for Secondary ASCVD Prevention Outcomes in a Federally Qualified Health Center

Led by University of Texas at Austin · Updated on 2026-03-11

1000

Participants Needed

1

Research Sites

17 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying how to improve care for patients with high cholesterol who have a history of clinical Atherosclerotic Cardiovascular Disease (ASCVD). This study focuses on optimizing cholesterol-lowering treatments, especially using non-statin medications, to help patients reach recommended LDL cholesterol goals. It is a prospective, observational research conducted at a federally qualified health center involving about 1,000 patients. The study compares standard care provided by clinical pharmacists with an added outreach intervention by pharmacy interns. Clinical pharmacists review patients' recent lipid panels and adjust treatments according to guidelines, including statins, ezetimibe, or PCSK9 inhibitors as needed. The pharmacy intern reaches out to patients by telehealth to review medications, adherence, and labs, providing education under pharmacist supervision. Patients continue routine care regardless of study participation. Participants will be followed for 6 months with data collected from routine visits, medication records, and cholesterol levels. Researchers will assess the percentage of patients reaching LDL cholesterol targets and the impact of non-statin therapies. Patients will be contacted by phone for follow-up and may have appointments in person or via telehealth. The study monitors medication adherence, treatment changes, and cholesterol outcomes while maintaining patient privacy and offering continued clinical pharmacy support throughout.

CONDITIONS

Brief Title

Optimizing Non-statin Agents for ASCVD

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (older than 18 years)
  • Have seen a CommUnityCare provider in the previous 12 months
  • Documented history of clinical ASCVD
  • Not achieving LDL cholesterol targets (less than 55 or 70 mg/dL based on risk factors)
Not Eligible

You will not qualify if you...

  • No clearly documented history of clinical ASCVD
  • Already achieving LDL cholesterol targets (less than 55 or 70 mg/dL based on risk factors)
  • Cholesterol managed by an outside provider (e.g., cardiologist or lipid specialist)
  • Currently pregnant
  • Have not seen a CommUnityCare provider in the previous 12 months
  • Do not qualify for clinical pharmacy intervention

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or telehealth)

Outreach and Counseling

Duration - Occurs after clinical pharmacy appointment and informed consent

Eligible participants receive outreach calls by a student pharmacist to review current lipid-lowering therapies, medication adherence, and education. This outreach complements routine clinical pharmacy care without independent prescribing by the student pharmacist.

1 telehealth outreach call

Routine Clinical Pharmacy Care

Duration - Ongoing throughout the study period

Participants continue to receive standard care with clinical pharmacists who assess lipid panels, adjust therapies as needed, and provide follow-up either in-person or via telehealth.

Visits scheduled as per clinical pharmacy standard of care, including follow-up lipid panels 4-12 weeks after therapy adjustments

Follow-up Monitoring

Duration - 3 to 6 months

Participants are followed through chart review to evaluate LDL cholesterol outcomes and therapy effectiveness 3 to 6 months after consent and outreach.

No additional visits; monitoring through chart review

Trial Site Locations

Total: 1 location

1

CommUnityCare Health Centers

Austin, Texas, United States, 78741

Actively Recruiting

Loading map...

Research Team

M

Morgan Stewart, PharmD

K

Kathryn Lin, PharmD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Effects of IL-1 Beta Inhibition on Vascular Inflammation in ...

Vascular Inflammation

Actively Recruiting

1 location

A Multicenter, Randomized, Double-blind, Placebo-controlled ...

Atherosclerosis Cardiovascular Disease

Actively Recruiting

33 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here